1 / 12

The TLR5 1174C>T Polymorphism in Melioidosis Infection

The TLR5 1174C>T Polymorphism in Melioidosis Infection. Chief of Medicine Conference 10/2/12 Presented by Amy Dickey, MD R2, Internal Medicine Principal Investigator: Eoin West, MD MPH. Outline. Background: What is m elioidosis ? What are Toll Like Receptors?

Download Presentation

The TLR5 1174C>T Polymorphism in Melioidosis Infection

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The TLR51174C>T Polymorphism in Melioidosis Infection Chief of Medicine Conference 10/2/12 Presented by Amy Dickey, MD R2, Internal Medicine Principal Investigator: Eoin West, MD MPH

  2. Outline • Background: • What is melioidosis? • What are Toll Like Receptors? • How is the TLR51174C>T polymorphism important in mortality from melioidosis? • Hypothesis– Defining the role of the TLR51174C>T polymorphism in cell signaling. • Data • Conclusions and future directions

  3. Melioidosis • Melioidosis– the disease caused by the pathogen Burkholderiapseudomallei • An important cause of pneumonia and sepsis in SE Asia and northern Australia. • The mortality rate from melioidosis can reach 40%. Figure 1. The global distribution of Melioidosis. NEJM Sept 13, 2012.

  4. Flagellin is the TLR5 agonist • Toll Like Receptors are signaling receptors of the innate immune system. • They recognize molecules shared by pathogens called pathogen-associated molecular patterns (PAMPs). • Important antigens containing PAMPs include LPS, flagellin, and lipopeptides Figure 2: Toll like receptor signaling pathways

  5. The TLR51174C>T non-functional polymorphism improves survival from melioidosis. • The TLR51174C>T polymorphism encodes a premature stop codon in the ligand-binding domain of TLR5. • In a cohort of Thai melioidosis patients, those with the TLR51174C>Tpolymorphism experienced a 3x decrease in in-hospital mortality from melioidosisinfection. TLR5 TLR5 mutant Table 1: TLR51174C>T genotype and in-hospital mortality

  6. Surprisingly, the TLR51174C>T polymorphism modulates cytokine response to both flagellin and LPS. Figure 4. IL-8 expression Figure 3. GCSF expression

  7. Hypothesis • TLR51174C>T polymorphism modulates the TLR4-dependent innate immune response to B. pseudomallei. LPS TLR5 TLR4 TLR5 mutant ? ? NF-kB Inflammatory Cytokines

  8. The TLR51174C>T polymorphism increases NF-kB expression in response to LPS. Figure 6. NF-kB activation

  9. Surprisingly, the TLR5 polymorphism increases NF-kB expression but decreases IL8 expression in response to LPS. Figure 7. NF-kB activation Figure 8. IL-8 expression

  10. The TLR51174C>T polymorphism attenuates IL8 expression in response to B. pseudomallei, an effect independent of flagellin. Figure 9: IL-8 expression assay

  11. Conclusion • Conclusion: TLR51174C>T polymorphism modulates the TLR4-dependent innate immune response to Burkholderiapseudomallei. Specifically, the TLR51174C>T polymorphism alters TLR4-dependent NF-kB activation and IL-8 expression. • Additional Questions: Does the mutant TLR5 or the wild type TLR5 modulate TLR4-dependent signaling? At what level does it modulate signaling? LPS TLR5 TLR4 TLR5 mutant NF-kB Inflammatory Cytokines

  12. Acknowledgements The West Lab • Eoin West, MD MPH • Sudeshna Seal, PhD • Johanna Robertson Members of the Wurfel and Skerrett labs.

More Related